Jeffrey Weber
MD, PhD
Deputy Director, Laura and Isaac Perlmutter Cancer Center
👥Biography 个人简介
Jeffrey Weber led the CheckMate 238 trial establishing adjuvant nivolumab as a treatment option for resected melanoma with superior efficacy and tolerability over ipilimumab. His extensive work on immunotherapy biomarkers and toxicity management has informed clinical practice globally. He continues to lead innovation in melanoma adjuvant and neoadjuvant strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeffrey Weber 的研究动态
Follow Jeffrey Weber's research updates
留下邮箱，当我们发布与 Jeffrey Weber（NYU Langone Health）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment